User login
A Second-Line Treatment Option for Hepatocellular Carcinoma
In this special supplement to Federal Practitioner, Dr. Binu John of the University of Miami discusses the challenges and treatment options for Hepatocellular Carcinoma (HCC), a common type of liver cancer, with a focus on patients with Child-Pugh B cirrhosis. It highlights the increasing incidence of liver cancer, especially in the context of cirrhosis caused by various factors, and the significance of early diagnosis and curative treatment in improving survival rates.
In this special supplement to Federal Practitioner, Dr. Binu John of the University of Miami discusses the challenges and treatment options for Hepatocellular Carcinoma (HCC), a common type of liver cancer, with a focus on patients with Child-Pugh B cirrhosis. It highlights the increasing incidence of liver cancer, especially in the context of cirrhosis caused by various factors, and the significance of early diagnosis and curative treatment in improving survival rates.
In this special supplement to Federal Practitioner, Dr. Binu John of the University of Miami discusses the challenges and treatment options for Hepatocellular Carcinoma (HCC), a common type of liver cancer, with a focus on patients with Child-Pugh B cirrhosis. It highlights the increasing incidence of liver cancer, especially in the context of cirrhosis caused by various factors, and the significance of early diagnosis and curative treatment in improving survival rates.